| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Dec 19, 2025 | Dec 23, 2025 | Protalix BioTherapeutics, Inc. | CEO | Buy | 82.5 | +56,000 | 2.26% | ✗ | $101.4K |
| Oct 19, 2023 | Oct 20, 2023 | Protalix BioTherapeutics, Inc. | CEO | Buy | 95.0 | +64,516 | 94.88% | ✗ | $90.5K |
| Apr 11, 2022 | Apr 13, 2022 | Protalix BioTherapeutics, Inc. | CEO | Buy | 90.0 | +68,000 | 6.26% | ✗ | $102K |